SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LRMR

Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · USD
Healthcare · Biotechnology
$3.14-$0.08 (-2.48%)
 
Market cap
$329M
Insider Score
Analyst consensus
Market Cap$328.55M-6.8%
Revenue (ttm)n/a
Net Income-$156.03M
EPS-$1.67
Shares Out104.63M
PE Ration/a
Forward PE-3.47
Dividendn/a
Ex-Dividend Daten/a
Volume1,707,224
Open$3.15
Previous Close$3.22
Day's Range$2.96 - $3.22
52-Week Range$1.92 - $6.42
Beta0.69
AnalystsStrong Buy
Price Target$14.20(+352.23%)
Earnings DateNov 16, 2026

About LRMR

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Address
Three Bala Plaza East, Bala Cynwyd, PA, 19004, United States
Market Cap
329 million
Employees
71
Industrial Classification
Biotechnology

Larimar Therapeutics, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
56th Percentile Overall Score
LRMR InsiderScore:73 / 99

Larimar Therapeutics, Inc. scored higher than 56% of companies evaluated by InsiderBuying, and ranked 33rd out of 103 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Larimar Therapeutics, Inc. bought $392.1K of stock across 8 purchases in the last 90 days, the largest of them $187.1K.

Stake Increase

The average purchase added about 46% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$26.12M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.48%
5 Days
+3.97%
1 Month
+38.33%
6 Months
-8.99%
1 Year
-6.82%

$LRMR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LRMR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LRMR's directors and management

Net Shares Purchased by Insiders−6M−3M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LRMR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New LRMR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LRMR from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from LRMR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
71.03
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
62

News check: Analyst maintained positive rating despite price target cut; regulatory progress on lead program offsets mixed near-term signals.

Recent Insider Activity

Buys
17
Sells
0
Buy Value
$26.12M
Distinct Buyers
10

Insider Score Trend Over Time

-1.3 since Nov 13
0255075100Nov 13 — Insider Score 73.7Nov 14 — Insider Score 73.7Nov 15 — Insider Score 73.7Nov 16 — Insider Score 73.6Nov 17 — Insider Score 72.5Nov 18 — Insider Score 72.4Nov 19 — Insider Score 72.5Nov 20 — Insider Score 72.5Nov 21 — Insider Score 72.4Nov 22 — Insider Score 72.4Nov 13Nov 17Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.23%
IBRNiShares Neuroscience and Healthcare ETF0.11%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.09%
FSEGFidelity Enhanced Small Cap Growth ETF0.07%
FSCCFederated Hermes MDT Small Cap Core ETF0.06%
FSEVFidelity Enhanced Small Cap Value ETF0.05%
FESMFidelity Enhanced Small Cap ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
BIBProShares Ultra Nasdaq Biotechnology0.01%
IBBiShares Biotechnology ETF0.01%
VHTVanguard Health Care ETF0.00%

Weight is the stock’s share of each fund’s holdings.